239 related articles for article (PubMed ID: 21366911)
21. Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.
Petrou P; Gothelf Y; Argov Z; Gotkine M; Levy YS; Kassis I; Vaknin-Dembinsky A; Ben-Hur T; Offen D; Abramsky O; Melamed E; Karussis D
JAMA Neurol; 2016 Mar; 73(3):337-44. PubMed ID: 26751635
[TBL] [Abstract][Full Text] [Related]
22. Autologous hematopoietic cell transplantation for multiple sclerosis: a systematic review.
Reston JT; Uhl S; Treadwell JR; Nash RA; Schoelles K
Mult Scler; 2011 Feb; 17(2):204-13. PubMed ID: 20921236
[TBL] [Abstract][Full Text] [Related]
23. Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis.
Riordan NH; Morales I; Fernández G; Allen N; Fearnot NE; Leckrone ME; Markovich DJ; Mansfield D; Avila D; Patel AN; Kesari S; Paz Rodriguez J
J Transl Med; 2018 Mar; 16(1):57. PubMed ID: 29523171
[TBL] [Abstract][Full Text] [Related]
24. The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): study protocol for a randomized controlled trial.
Straudi S; Manfredini F; Lamberti N; Zamboni P; Bernardi F; Marchetti G; Pinton P; Bonora M; Secchiero P; Tisato V; Volpato S; Basaglia N
Trials; 2017 Feb; 18(1):88. PubMed ID: 28241776
[TBL] [Abstract][Full Text] [Related]
25. Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial).
Wu X; Xia Y; Zhou O; Song Y; Zhang X; Tian D; Li Q; Shu C; Liu E; Yuan X; He L; Liu C; Li J; Liang X; Yang K; Fu Z; Zou L; Bao L; Dai J
Trials; 2020 Jan; 21(1):125. PubMed ID: 32005282
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial.
Chataway J; De Angelis F; Connick P; Parker RA; Plantone D; Doshi A; John N; Stutters J; MacManus D; Prados Carrasco F; Barkhof F; Ourselin S; Braisher M; Ross M; Cranswick G; Pavitt SH; Giovannoni G; Gandini Wheeler-Kingshott CA; Hawkins C; Sharrack B; Bastow R; Weir CJ; Stallard N; Chandran S;
Lancet Neurol; 2020 Mar; 19(3):214-225. PubMed ID: 31981516
[TBL] [Abstract][Full Text] [Related]
27. Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury.
Mendonça MV; Larocca TF; de Freitas Souza BS; Villarreal CF; Silva LF; Matos AC; Novaes MA; Bahia CM; de Oliveira Melo Martinez AC; Kaneto CM; Furtado SB; Sampaio GP; Soares MB; dos Santos RR
Stem Cell Res Ther; 2014 Nov; 5(6):126. PubMed ID: 25406723
[TBL] [Abstract][Full Text] [Related]
28. First-in-man mesenchymal stem cells for radiation-induced xerostomia (MESRIX): study protocol for a randomized controlled trial.
Grønhøj C; Jensen DH; Glovinski PV; Jensen SB; Bardow A; Oliveri RS; Specht L; Thomsen C; Darkner S; Kiss K; Fischer-Nielsen A; von Buchwald C
Trials; 2017 Mar; 18(1):108. PubMed ID: 28270226
[TBL] [Abstract][Full Text] [Related]
29. Intra-discal injection of autologous, hypoxic cultured bone marrow-derived mesenchymal stem cells in five patients with chronic lower back pain: a long-term safety and feasibility study.
Elabd C; Centeno CJ; Schultz JR; Lutz G; Ichim T; Silva FJ
J Transl Med; 2016 Sep; 14(1):253. PubMed ID: 27585696
[TBL] [Abstract][Full Text] [Related]
30. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.
Honmou O; Houkin K; Matsunaga T; Niitsu Y; Ishiai S; Onodera R; Waxman SG; Kocsis JD
Brain; 2011 Jun; 134(Pt 6):1790-807. PubMed ID: 21493695
[TBL] [Abstract][Full Text] [Related]
31. Fluoxetine in progressive multiple sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial.
Cambron M; Mostert J; Haentjens P; D'Hooghe M; Nagels G; Willekens B; Heersema D; Debruyne J; Van Hecke W; Algoed L; De Klippel N; Fosselle E; Laureys G; Merckx H; Van Wijmeersch B; Vanopdenbosch L; Verhagen W; Hupperts R; Hengstman G; Michiels V; Van Merhaegen-Wieleman A; De Keyser J
Trials; 2014 Jan; 15():37. PubMed ID: 24460863
[TBL] [Abstract][Full Text] [Related]
32. Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial.
Wolinsky JS; Arnold DL; Brochet B; Hartung HP; Montalban X; Naismith RT; Manfrini M; Overell J; Koendgen H; Sauter A; Bennett I; Hubeaux S; Kappos L; Hauser SL
Lancet Neurol; 2020 Dec; 19(12):998-1009. PubMed ID: 33129442
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of neurotrophic factor secreting mesenchymal stem cells in progressive multiple sclerosis.
Cohen JA; Lublin FD; Lock C; Pelletier D; Chitnis T; Mehra M; Gothelf Y; Aricha R; Lindborg S; Lebovits C; Levy Y; Motamed Khorasani A; Kern R
Mult Scler; 2023 Jan; 29(1):92-106. PubMed ID: 36113170
[TBL] [Abstract][Full Text] [Related]
34. Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study.
Lublin FD; Bowen JD; Huddlestone J; Kremenchutzky M; Carpenter A; Corboy JR; Freedman MS; Krupp L; Paulo C; Hariri RJ; Fischkoff SA
Mult Scler Relat Disord; 2014 Nov; 3(6):696-704. PubMed ID: 25891548
[TBL] [Abstract][Full Text] [Related]
35. Effects of Mesenchymal Stem Cell Transplantation on Cerebrospinal Fluid Biomarkers in Progressive Multiple Sclerosis.
Petrou P; Kassis I; Ginzberg A; Hallimi M; Karussis D
Stem Cells Transl Med; 2022 Mar; 11(1):55-58. PubMed ID: 35641166
[TBL] [Abstract][Full Text] [Related]
36. Randomized clinical trial: expanded autologous bone marrow mesenchymal cells combined with allogeneic bone tissue, compared with autologous iliac crest graft in lumbar fusion surgery.
García de Frutos A; González-Tartière P; Coll Bonet R; Ubierna Garcés MT; Del Arco Churruca A; Rivas García A; Matamalas Adrover A; Saló Bru G; Velazquez JJ; Vila-Canet G; García-Lopez J; Vives J; Codinach M; Rodriguez L; Bagó Granell J; Càceres Palou E
Spine J; 2020 Dec; 20(12):1899-1910. PubMed ID: 32730985
[TBL] [Abstract][Full Text] [Related]
37. Designing Multi-arm Multistage Adaptive Trials for Neuroprotection in Progressive Multiple Sclerosis.
Li V; Leurent B; Barkhof F; Braisher M; Cafferty F; Ciccarelli O; Eshaghi A; Gray E; Nicholas JM; Parmar M; Peryer G; Robertson J; Stallard N; Wason J; Chataway J
Neurology; 2022 May; 98(18):754-764. PubMed ID: 35321926
[TBL] [Abstract][Full Text] [Related]
38. Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis.
Llufriu S; Sepúlveda M; Blanco Y; Marín P; Moreno B; Berenguer J; Gabilondo I; Martínez-Heras E; Sola-Valls N; Arnaiz JA; Andreu EJ; Fernández B; Bullich S; Sánchez-Dalmau B; Graus F; Villoslada P; Saiz A
PLoS One; 2014; 9(12):e113936. PubMed ID: 25436769
[TBL] [Abstract][Full Text] [Related]
39. TOOTH (The Open study Of dental pulp stem cell Therapy in Humans): Study protocol for evaluating safety and feasibility of autologous human adult dental pulp stem cell therapy in patients with chronic disability after stroke.
Nagpal A; Kremer KL; Hamilton-Bruce MA; Kaidonis X; Milton AG; Levi C; Shi S; Carey L; Hillier S; Rose M; Zacest A; Takhar P; Koblar SA
Int J Stroke; 2016 Jul; 11(5):575-85. PubMed ID: 27030504
[TBL] [Abstract][Full Text] [Related]
40. Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study.
Fernández O; Izquierdo G; Fernández V; Leyva L; Reyes V; Guerrero M; León A; Arnaiz C; Navarro G; Páramo MD; Cuesta A; Soria B; Hmadcha A; Pozo D; Fernandez-Montesinos R; Leal M; Ochotorena I; Gálvez P; Geniz MA; Barón FJ; Mata R; Medina C; Caparrós-Escudero C; Cardesa A; Cuende N;
PLoS One; 2018; 13(5):e0195891. PubMed ID: 29768414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
